Angela Qu, M.D., Ph.D.

SVP, Biomarker Genomic Medicine

Connect with me

An expert in biomarkers, genomics, precision medicine, and innovative trial design and execution, Angela has more than 25 years of experience in a broad range of therapeutic areas, including oncology, immunology, CNS, metabolic, and rare disease drug development. She has led genomics- and biomarker-based development projects from the preclinical through late clinical stages. She is a core member of Parexel’s Oncology Center of Excellence and Rare Disease Working Group and has published more than 50 peer-reviewed journal articles on translational medicine and drug development.